Patient adherence to tuberculosis treatment in the Indian subcontinent: systematic review and meta-synthesis of qualitative research.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
04 05 2023
Historique:
medline: 8 5 2023
pubmed: 5 5 2023
entrez: 4 5 2023
Statut: epublish

Résumé

How well patients adhere to their tuberculosis (TB) treatment influences their recovery and development of drug resistance, but influences on adherence are multiple and often competing. We synthesised qualitative studies from our setting in the Indian subcontinent to understand the dimensions and dynamics involved to help inform service provision. Qualitative synthesis comprising inductive coding, thematic analysis and forming a conceptual framework. Medline (OVID), Embase (OVID), CINAHL (EBSCOHost), PsycINFO (EBSCOHost), Web of Science Core Collection, Cochrane Library and Epistemonikos were databases searched on 26 March 2020 for studies published since 1 January 2000. We included reports in English from the Indian subcontinent that used qualitative or mixed-methodology designs and reported findings around adherence to TB treatment. Full texts meeting eligibility were sampled based on 'thickness' (the richness of the qualitative data reported). Two reviewers used standardised methods to screen abstracts and code. Included studies were assessed for reliability and quality using a standard tool. Qualitative synthesis was performed by inductive coding, thematic analysis and developing conceptual framework. Of 1729 abstracts screened from initial search, 59 were shortlisted for full-text review. Twenty-four studies that qualified as 'thick' were included in the synthesis. Studies were set in India (12), Pakistan (6), Nepal (3), Bangladesh (1) or in two or more of these countries (2). Of the 24 studies, all but one included people who were taking TB treatment (1 study included only healthcare providers), and 17 included healthcare workers, community members or both.We identified three themes: (1) personal influences on the people with TB include interconnections between their social role in the family unit, their own priorities in day-to-day living and their experience to date with the disease; (2) adherence is profoundly influenced by how individual healthcare providers interact with patients on treatment and address their needs; (3) adherence is influenced across communities by structural, social, economic and cultural factors related to treatment. Staff in TB programmes require an understanding of the various competing influences on individuals undergoing treatment. Programmes need to have more flexible and people-centred approaches to service provision in order to achieve adherence, and thus improve treatment outcomes. CRD42020171409.

Identifiants

pubmed: 37142319
pii: bmjopen-2022-063926
doi: 10.1136/bmjopen-2022-063926
pmc: PMC10163483
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e063926

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Multidiscip Respir Med. 2018 Mar 22;13:10
pubmed: 29599974
BMC Med Res Methodol. 2012 Nov 27;12:181
pubmed: 23185978
BMC Public Health. 2014 Jan 17;14:46
pubmed: 24438351
PLoS One. 2020 Jan 15;15(1):e0227293
pubmed: 31940375
BMC Health Serv Res. 2016 Jul 19;16:283
pubmed: 27430557
PLoS Med. 2007 Feb;4(2):e37
pubmed: 17298164
Trop Med Int Health. 2013 Sep;18(9):1128-1133
pubmed: 23837468
Int J Tuberc Lung Dis. 1999 Apr;3(4):300-9
pubmed: 10206500
Int J Tuberc Lung Dis. 2006 Sep;10(9):1008-12
pubmed: 16964792
Qual Health Res. 2019 Jul;29(8):1109-1119
pubmed: 30499375
PLoS One. 2019 Jan 10;14(1):e0210408
pubmed: 30629648
Health Policy Plan. 2005 Nov;20(6):354-65
pubmed: 16183735
PLoS One. 2015 Aug 24;10(8):e0135802
pubmed: 26301748
Int J Tuberc Lung Dis. 2001 Oct;5(10):887-93
pubmed: 11605880
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
PLoS Med. 2007 Jul 24;4(7):e238
pubmed: 17676945
Glob Public Health. 2014;9(10):1239-51
pubmed: 25223868
BMC Health Serv Res. 2013 Jul 31;13:290
pubmed: 23899353
Am Rev Respir Dis. 1991 Oct;144(4):745-9
pubmed: 1928942
PLoS Med. 2018 Jul 3;15(7):e1002595
pubmed: 29969463
Public Health Action. 2018 Dec 21;8(4):187-193
pubmed: 30775279
BMC Public Health. 2009 Jun 17;9:190
pubmed: 19534811
Bull World Health Organ. 2008 Mar;86(3):B-D
pubmed: 18368191
Trop Med Int Health. 2002 Aug;7(8):693-700
pubmed: 12167096
Lancet. 2014 Sep 20;384(9948):1095
pubmed: 25241715
BMJ Open. 2018 Jan 21;8(1):e019287
pubmed: 29358443
Cochrane Database Syst Rev. 2015 Sep 03;(9):CD007952
pubmed: 26333525
J Family Med Prim Care. 2022 Jun;11(6):3006-3012
pubmed: 36119340
Lancet. 2000 Apr 15;355(9212):1345-50
pubmed: 10776760
Int J Tuberc Lung Dis. 2008 Jul;12(7):837-47
pubmed: 18544214
J Epidemiol Glob Health. 2017 Dec;7(4):219-225
pubmed: 29110861
BMJ Open. 2019 Jul 9;9(7):e025707
pubmed: 31289061
Int J Prev Med. 2010 Fall;1(4):223-32
pubmed: 21566777
Ethiop Med J. 1994 Apr;32(2):97-106
pubmed: 8033883
Indian J Public Health. 2022 Jan-Mar;66(1):38-44
pubmed: 35381712
Int J Tuberc Lung Dis. 2002 Sep;6(9):780-8
pubmed: 12234133
PLoS One. 2015 Nov 12;10(11):e0142384
pubmed: 26562787
Int J Tuberc Lung Dis. 2004 Dec;8(12):1492-8
pubmed: 15636497
Anthropol Med. 2007 Aug;14(2):139-51
pubmed: 27268389
Int J Tuberc Lung Dis. 1998 Nov;2(11):891-7
pubmed: 9848609
Indian J Tuberc. 2007 Apr;54(2):66-70
pubmed: 17575677
J Trop Pediatr. 2017 Aug 1;63(4):274-285
pubmed: 28082666
Int J Tuberc Lung Dis. 2004 Oct;8(10):1260-5
pubmed: 15527160
Cochrane Database Syst Rev. 2022 Feb 17;2:CD013638
pubmed: 35174482
PLoS Med. 2019 Dec 10;16(12):e1002884
pubmed: 31821323
Cochrane Database Syst Rev. 2015 May 29;(5):CD003343
pubmed: 26022367
Tanaffos. 2013;12(4):28-34
pubmed: 25191481
PLoS One. 2016 Mar 09;11(3):e0150849
pubmed: 26959366
Trop Med Int Health. 2003 Jul;8(7):625-33
pubmed: 12828545
Kekkaku. 2008 Dec;83(12):765-72
pubmed: 19172821
Bull World Health Organ. 2007 May;85(5):404-6
pubmed: 17639229
Glob Health Action. 2019;12(1):1568826
pubmed: 30712507
Health Promot Int. 2015 Jun;30(2):262-9
pubmed: 23793302
PLoS One. 2016 Mar 21;11(3):e0151321
pubmed: 26998830
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
Southeast Asian J Trop Med Public Health. 2008 Nov;39(6):1076-82
pubmed: 19062698
Int J Tuberc Lung Dis. 2014 Dec;18(12):1479-84
pubmed: 25517815
PLoS One. 2010 Apr 06;5(4):e10043
pubmed: 20386611
PLoS One. 2014 Feb 03;9(2):e88290
pubmed: 24498440
Am J Public Health. 2011 Apr;101(4):654-62
pubmed: 21330583
Int J Tuberc Lung Dis. 2002 Jul;6(7):573-9
pubmed: 12102295
Trop Med Int Health. 2004 Jul;9(7):833-41
pubmed: 15228495
Am J Speech Lang Pathol. 2015 Nov;24(4):S838-53
pubmed: 26140581
Int J Infect Dis. 2009 May;13(3):362-8
pubmed: 19008141
J Health Popul Nutr. 2010 Apr;28(2):114-23
pubmed: 20411673
Cochrane Database Syst Rev. 2014 Nov 18;(11):CD006594
pubmed: 25403701
Clin Infect Dis. 2013 Jul;57(1):21-31
pubmed: 23487389
BMC Public Health. 2011 Mar 25;11:188
pubmed: 21439062

Auteurs

Kalpita Shringarpure (K)

Department of Community Medicine, Medical College Baroda, Baroda, Gujarat, India kshringarpure@gmail.com.

Meera Gurumurthy (M)

Research Division, Vital Strategies, Singapore.
TB Department, International Union Against Tuberculosis and Lung Disease (The Union), South East Asia Office, New Delhi, India.

Karuna D Sagili (KD)

TB Department, International Union Against Tuberculosis and Lung Disease (The Union), South East Asia Office, New Delhi, India.

Melissa Taylor (M)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.

Paul Garner (P)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.

Jamie Tonsing (J)

TB Department, International Union Against Tuberculosis and Lung Disease (The Union), South East Asia Office, New Delhi, India.
The Global Fund to Fight AIDS Tuberculosis and Malaria, Grand-Saconnex, Geneva, Switzerland.

Raghuram Rao (R)

National Tuberculosis Elimination Programme (NTEP), Central TB Division, India Ministry of Health and Family Welfare, New Delhi, India.

Kuldeep Singh Sachdeva (KS)

TB Department, International Union Against Tuberculosis and Lung Disease (The Union), South East Asia Office, New Delhi, India.
National Tuberculosis Elimination Programme (NTEP), Central TB Division, India Ministry of Health and Family Welfare, New Delhi, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH